Page last updated: 2024-11-01

niclosamide and Asthma, Bronchial

niclosamide has been researched along with Asthma, Bronchial in 2 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ousingsawat, J1
Centeio, R1
Cabrita, I2
Talbi, K1
Zimmer, O1
Graf, M1
Göpferich, A1
Schreiber, R2
Kunzelmann, K2
Benedetto, R1

Other Studies

2 other studies available for niclosamide and Asthma, Bronchial

ArticleYear
Airway Delivery of Hydrogel-Encapsulated Niclosamide for the Treatment of Inflammatory Airway Disease.
    International journal of molecular sciences, 2022, Jan-19, Volume: 23, Issue:3

    Topics: Animals; Asthma; Cells, Cultured; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Drug Ca

2022
Niclosamide repurposed for the treatment of inflammatory airway disease.
    JCI insight, 2019, 08-08, Volume: 4, Issue:15

    Topics: Animals; Anoctamins; Anti-Inflammatory Agents; Asthma; Bronchi; Cell Line, Tumor; Cystic Fibrosis; D

2019